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Abstract 
Follicle stimulating hormone (FSH) and androgen act to stimulate and maintain spermatogenesis. 
FSH acts directly on the Sertoli cells to stimulate germ cell number and acts indirectly to increase 
androgen production by the Leydig cells. In order to differentiate between the direct effects of 
FSH on spermatogenesis and those mediated indirectly through androgen action we have crossed 
hypogonadal (hpg) mice which lack gonadotrophins with mice lacking androgen receptors (AR)  
either ubiquitously (ARKO) or specifically on the Sertoli cells (SCARKO).  These hpg.ARKO 
and hpg.SCARKO mice were treated with recombinant FSH for 7 days and testicular morphology 
and cell numbers assessed. In untreated hpg and hpg.SCARKO mice germ cell development was 
limited and did not progress beyond the pachytene stage. In hpg.ARKO mice testes were smaller 
with fewer Sertoli cells and germ cells compared to hpg mice. Treatment with FSH had no effect 
on Sertoli cell number but significantly increased germ cell numbers in all groups. In hpg mice 
FSH increased numbers of spermatogonia and spermatocytes and induced round spermatid 
formation.  In hpg.SCARKO and hpg.ARKO mice, in contrast, only spermatogonial and 
spermatocyte numbers were increased with no formation of spermatids. Leydig cell numbers 
were increased by FSH in hpg and hpg.SCARKO mice but not in hpg.ARKO mice. Results show 
that in rodents 1) FSH acts to stimulate spermatogenesis through an increase in spermatogonial 
number and subsequent entry of these cells into meiosis, 2) FSH has no direct effect on the 
completion of meiosis and 3) FSH effects on Leydig cell number are mediated through interstitial 
ARs. 
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Introduction 
Sertoli cell function and spermatogenesis are dependent upon the actions of follicle-stimulating 
hormone (FSH) and androgen. This is clearly seen in hypogonadal (hpg) mice which lack 
circulating FSH and luteinising hormone (LH) and are infertile with associated failure of the germ 
cells to progress beyond early meiosis (Cattanach et al. 1977). Treatment of hpg mice with FSH 
stimulates germ cell proliferation, with an increase in spermatogonial and spermatocyte numbers, 
and induces spermatid formation (Singh & Handelsman 1996). This is similar to the effects of 
FSH in the GnRH-immunized or hypophysectomised  rat (McLachlan et al. 1995; Vihko et al. 
1991; Russell et al. 1993) and in tandem with studies on FSH-receptor knockout (FSHRKO) mice 
our current understanding is  that the primary function of FSH is to maintain germ cell numbers 
and to promote germ cell progression through meiosis (Dierich et al. 1998).  One major problem 
with the study of FSH action in these models, however, is dissociating the effects of FSH from 
those of androgen. In early studies the FSH preparations used contained low levels of LH which 
could induce androgen production by the  Leydig cells. Use of recombinant FSH has overcome 
this problem but there remains the issue that FSH has been shown to induce Leydig cell function, 
probably indirectly through stimulation of the Sertoli cells (Johnson & Ewing 1971; Chen et al. 
1976; Vihko et al. 1991).  We have shown that FSH will increase androgen levels in the hpg testis 
and that it will induce expression of androgen-dependent Sertoli cell genes such as Rhox5 (Abel 
et al. 2009). It remains likely, therefore, that some of the effects of FSH on spermatogenesis, seen 
in models such as the hpg or hypophysectomised animal, are mediated indirectly through 
stimulation of androgen production. To investigate the role of androgen in mediating FSH action, 
and to identify the direct effects of FSH, we have generated hpg mice lacking androgen receptors 
(AR) either ubiquitously (hpg.ARKO) or specifically on the Sertoli cells (hpg.SCARKO).  
Treatment of these mice with FSH allows us to dissect the direct effects of FSH on testicular 
function from those mediated by androgen action through the Sertoli cell or other androgen-
responsive cells in the testis. 
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Results 
Testis volume, seminal vesicle weight and testosterone levels 
Testicular volume was similar in hpg and hpg.SCARKO mice but was significantly reduced in 
hpg.ARKO mice (Fig 1). Treatment of the animals with FSH for 7 days increased testis volume 
significantly in all 3 groups. Seminal vesicle weights were similar in hpg and hpg.SCARKO mice 
and were significantly increased by FSH (Table 1). The hpg.ARKO mice do not develop seminal 
vesicles. Intratesticular testosterone levels were significantly increased in hpg mice after 7 days 
treatment with FSH but were unaffected in hpg.SCARKO or hpg.ARKO mice (Fig 1). For 
comparison, intratesticular testosterone levels in normal adult mice are about 50pmol/testis 
(Baker et al. 2003; O’Shaughnessy et al. 2008). 
 
Morphology  
As described previously, and with the variation noted in Materials & Methods, spermatogenesis 
in untreated hpg mice was severely disrupted with spermatocyte progression only as far as the 
pachytene stage and no spermatids present (Fig 2). Few Leydig cells were apparent within the 
interstitial space (Fig 2). Testes from untreated hpg.SCARKO mice had a similar morphology 
with spermatogenesis progressing to the primary spermatocyte stage (Fig 2 ). In hpg.ARKO mice 
the tubules were smaller and while spermatogenesis progressed to the same stage as the hpg mice 
fewer spermatocytes were apparent. Crystalline structures with the appearance of microliths were 
present in some tubules as previously reported (O’Shaughnessy et al. 2009). 
 Treatment of hpg mice with FSH caused an increase in seminiferous tubule diameter 
(Figs 2 & 3), clear establishment of a tubular lumen and an increase in germ cell number (Fig 2). 
In some tubules spermatogenesis progressed to the round spermatid stage (Fig 2). In 
hpg.SCARKO and hpg.ARKO mice there was also an increase in tubule diameter although not as 
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marked as in the hpg (Fig 2 & 3) and, while there was a clear increase in germ cell number, there 
was no apparent progression beyond the primary spermatocyte stage.  
 FSH treatment caused an apparent increase in interstitial space and cell numbers in hpg 
and hpg.SCARKO mice (Fig 2). There was no clear effect of FSH on the interstitium of the 
hpg.ARKO mouse (Fig 2). 
 
Stereology 
Sertoli cell number was similar in hpg and hpg.SCARKO mice but was significantly 
reduced in hpg.ARKO mice (Fig 3). Treatment with FSH had no significant effect on Sertoli cell 
number in any group. Leydig cell number was similar in hpg and hpg.SCARKO mice but  was 
slightly reduced in hpg.ARKO mice compared to the hpg.SCARKO (Fig 3). Treatment with FSH 
increased Leydig cell number in hpg and hpg.SCARKO mice but had no effect in hpg.ARKO 
mice.   
Spermatogonial, spermatocyte and total germ cell numbers were similar in hpg and 
hpg.SCARKO mice but were significantly reduced in hpg.ARKO mice (Fig 4). Treatment with 
FSH increased total germ cell number in all three groups by 3-4 fold (Fig 4). Statistical analysis 
showed no interaction between the effects of FSH and animal phenotype indicating that the effect 
of FSH was similar in all three groups. Further analysis of germ cell types showed that 
spermatogonial and spermatocyte numbers  were increased by FSH in all groups with no 
significant interaction. As indicated above, FSH treatment induced development of round 
spermatids only in hpg mice and not in hpg.SCARKO or hpg.ARKO mice. 
 
Discussion 
The function that FSH plays in the regulation of spermatogenesis in rodents and higher mammals 
has been the subject of considerable study, and continuing uncertainty, since the early pioneering 
work in the 1930s which showed that FSH could partially restore spermatogenesis in rats after 
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hypophysectomy (Greep et al. 1936). Problems with LH contamination of FSH preparations 
limited progress for a number of years but a major development in our understanding of FSH 
action in the rodent came with the generation of mice lacking FSH (FSHβKO) or the FSH-
receptor (FSHRKO) (Kumar et al. 1997; Abel et al. 2000; Krishnamurthy et al. 2000). These 
animals were fertile but they  showed that FSH was required for normal development of Sertoli 
cell and germ cell numbers (Kumar et al. 1997; Abel et al. 2000; Krishnamurthy et al. 2000). In 
addition, more recent study of mice lacking both FSHR and AR on the Sertoli cells showed  that 
FSH acts to increase the number of spermatogonia and the entry of these cells into meiosis (Abel 
et al. 2008). From these studies it was clear that FSH was required for normal testicular 
development but it still remained uncertain how many of the effects of FSH were mediated 
directly through FSH action and how many were dependent on indirect alteration of androgen 
levels. This study was designed, therefore, to determine which effects of FSH on testicular 
function are direct, which are dependent on androgen action and whether those effects of 
androgen are mediated through the Sertoli cell.   
Sertoli cell numbers in the mouse are normally determined by around post-natal day 15. 
Factors regulating Sertoli cell number are not fully understood but androgens, probably acting 
through the peritubular myoid cells (PMCs), stimulate proliferation in utero while FSH is 
required post-natally (Johnston et al. 2004; Tan et al. 2005). In the adult hpg mouse Sertoli cell 
numbers are about 50% of normal (Baker & O'Shaughnessy 2001; Haywood et al. 2003) 
reflecting the loss of both FSH and androgen post-natally in these mice. Interestingly,  there was a 
reduction in Sertoli cell numbers in the hpg.ARKO mice compared to the hpg. Androgen 
production by the hpg is minimal post-natally but is normal in utero (O'Shaughnessy et al. 1998) 
and Sertoli cell numbers are normal at birth (Baker & O'Shaughnessy 2001; Johnston et al. 2004). 
This contrasts with ARKO or  androgen-resistant Tfm mice which have reduced Sertoli cell 
number at birth (Johnston et al. 2004; Tan et al. 2005) suggesting that differences in Sertoli cell 
numbers between hpg and hpg.ARKO mice are likely to be due to androgen action in the fetal 
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testis.  The number of Sertoli cells in hpg.SCARKO mice was the same as in the hpg, consistent 
with data showing that SCARKO mice have a normal contingent of Sertoli cells (De Gendt et al. 
2004; Abel et al. 2008). This provides further confirmation that androgen effects on Sertoli cell 
numbers are independent of direct androgen action on the Sertoli cell (Johnston et al. 2004; Tan 
et al. 2005). Failure of FSH to affect Sertoli cell number in any group in this study, is consistent 
with earlier findings (Singh & Handelsman 1996; O'Shaughnessy et al. 1992) and indicates that 
the Sertoli cells in the adult hpg are no longer sensitive to the mitogenic effects of FSH.  
Differences in germ cell numbers between untreated hpg and hpg.ARKO mice could be 
due to the presence of very low levels of androgen in the post-natal hpg testis or, as above, to the 
effects of androgen action in utero. Androgen action in utero appears more likely since the 
presence of endogenous testicular androgen post-natally would probably lead to a difference in 
germ cell number between hpg and hpg.SCARKO mice as androgen action through the Sertoli 
cell is clearly required for normal germ cell development (De Gendt et al. 2004). If the effects are 
due to androgen action in utero, differences between hpg and hpg.SCARKO mice would not arise 
since Sertoli cells do not express ARs until after birth (Bremner et al. 1994; Zhou et al. 1996). In 
the fetal testis ARs are expressed predominantly on peritubular myoid cells which would suggest 
that differences in germ cell number between adult hpg and hpg.ARKO mice are due to androgen 
action through the peritubular myoid cells in utero. Interestingly, it has recently been shown that 
androgen action through the peritubular myoid cells is essential post-natally for development of 
normal spermatogenesis (Welsh et al. 2009).  It has been reported that primordial germ cells 
express the AR which would offer an alternative mode of action of androgens in utero (Merlet et 
al. 2007). The direct effect of androgen on the germ cells is reported to be inhibitory, however 
(Merlet et al. 2007), suggesting that this is unlikely to explain differences between hpg and 
hpg.ARKO mice.   
 A number of previous studies, using a variety of different models including the hpg 
mouse, hpg mouse expressing FSH, GnRH-immunized rat and hypophysectomised rat, have 
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reported that FSH acts to increase numbers of spermatogonia, spermatocytes and round 
spermatids (Vihko et al. 1991; Bremner et al. 1994; McLachlan et al. 1995; Russell et al. 1998; 
Haywood et al. 2003). In the hpg, hpg.SCARKO and hpg.ARKO models FSH increased total 
germ cell number and spermatogonial and spermatocyte numbers, consistent with earlier studies, 
and showed that these effects of FSH are independent of  androgen action through the Sertoli cell 
or any other androgen-responsive cell in the testis. FSH treatment also stimulated round 
spermatid formation in the hpg testis, as reported previously (Singh & Handelsman 1996; 
Haywood et al. 2003) although spermatid numbers were only about 5% of spermatocyte numbers.  
In contrast, FSH failed to stimulate generation of round spermatids in the hpg.SCARKO and 
hpg.ARKO mice showing that this effect of FSH is entirely dependent on androgen action 
through the Sertoli cells. This is consistent with earlier studies using hypophysectomised rats 
which showed that stimulation of post-meiotic germ cell formation by FSH was partially 
inhibited by the AR antagonist flutamide (Russell et al. 1998) or EDS which acts to destroy 
Leydig cells (Matikainen et al. 1994). One caveat to these studies is that the hpg mice used here 
will have developed in a gonadotrophin-free environment and may not, therefore, show the same 
response to FSH as the normal adult animal. The consistency between results using the hpg 
models and other data described above using different animal models would suggest, however, 
that  these results are relevant to normal spermatogenesis. Overall, therefore, results from this and 
earlier studies shows that in rodents FSH acts to stimulate spermatogenesis through an increase in 
spermatogonial number and subsequent entry of these cells into meiosis. Completion of meiosis 
appears to be absolutely dependent on the action of androgen.   
Generally, insofar as it has been studied, the effects of FSH appear to be similar across 
different mammalian species. In  Rhesus and Cynomolgus monkeys, FSH appears to act primarily 
to increase the number of spermatogonia (Marshall et al. 1986; 1995; Simorangkir et al. 2009) 
while in sheep immunization against FSH reduces spermatogonial  numbers (Kilgour et al.1998). 
The role of FSH in human spermatogenesis remains somewhat unclear since there is conflict 
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between the effects of FSHβ deletion and FSHR deletion (Tapanainen et al. 1997;  Lindstedt et 
al. 1998; Phillip et al. 1998; Layman et al. 2002) and because treatment of infertile 
hypogonadotrophic men is based on treatment with hCG making it difficult to establish effects of 
FSH.  Nevertheless, the prevailing evidence suggests that data from rodents is relevant generally 
and that the primary effect of FSH is to maintain spermatogenesis quantitatively through effects 
on spermatogonial numbers.  
 Numerous studies have shown that FSH will stimulate Leydig cell function through an 
indirect mechanism which is assumed to involve release of paracrine factors from the Sertoli cells 
following direct stimulation of the FSH-receptor (Vihko et al. 1991; Chen et al. 1976). In this 
study intratesticular testosterone levels were only increased by FSH in the hpg group and not the 
hpg.SCARKO or hpg.ARKO groups. This contrasts with  the increase in seminal vesicle weights 
after FSH  treatment in both hpg and hpg.SCARKO groups suggesting that there is an increase in 
testosterone in the hpg.SCARKO at the start of treatment but that this is not maintained up to 7 
days. Baines et al (Baines et al. 2008) have shown previously that FSH will increase Leydig cell 
number in the adult hpg. Our results confirm this observation and show that the effects of FSH on 
Leydig cell number in the hpg mouse are mediated through androgen action not involving the 
Sertoli cells. Since Leydig cells express ARs (Zhou et al. 2002) the simplest explanation is that 
FSH indirectly stimulates androgen production by the Leydig cells which, in turn, acts directly on 
the Leydig cells to induce proliferation or, possibly, differentiation from precursor stem cells. 
This is consistent with earlier data showing that Leydig cell number is reduced in Tfm and ARKO 
mice (O'Shaughnessy et al. 2002; De Gendt et al. 2005).  
 In conclusion, the design of this study has allowed us to dissect the direct effects of FSH 
away from those of androgen and to show that FSH acts only during the initial stages of 
spermatogenesis to optimise germ cell number. Results also demonstrate that FSH  cannot 
stimulate completion of meiosis which is entirely dependent on androgen action. 
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Materials & Methods 
Animals and treatments 
All mice were bred and all procedures carried out under UK Home Office Licence and with the 
approval of a local ethical review committee. SCARKO and ARKO mice have been previously 
generated by crossing female mice carrying an Ar with a floxed exon 2 (Arfl ) with male mice 
expressing Cre under the regulation of the Sertoli cell specific promoter Amh or the ubiquitous 
promoter Pgk-1 (Lecureuil et al. 2002; De Gendt et al. 2004). In order to produce hpg.SCARKO 
mice, hpg mice (C3HE/HeH-101/H) were initially crossed with mice carrying the Arfl allele 
(Swiss-Webster/129) and with mice carrying  the Amh-Cre transgene (C57-BL6/SJL).  From 
these crosses, female mice heterozygous for the GnRH deletion (hpg/+) and homozygous for the 
Arfl allele were crossed with hpg/+ Amh-Cre males (heterozygous or homozygous for Cre ) to 
generate hpg.SCARKO mice. The hpg deletion and Arfl  allele  were detected by PCR analysis of 
ear clip lysates (Lang 1991) and excision of the floxed Ar confirmed at termination by PCR of 
testicular DNA  (De Gendt et al. 2004). The generation of hpg.ARKO mice was  similar except 
that Pgk-Cre (C57-BL6/SJL) replaced Amh-Cre.  The hpg ARKO males were detected by PCR of 
ear clip lysates for Sry and deletion of GnRH  and confirmed at termination by the absence of 
epididymides, seminal vesicles and ductus deferens. The hpg mice used in this study were 
generated from the same litters producing hpg.SCARKO and hpg.ARKO mice. 
To determine the effects of FSH treatment, adult (10 weeks of age) male hpg, 
hpg.SCARKO and hpg.ARKO mice  were injected sub-cutaneously with 8 IU recombinant 
human FSH (rhFSH) (Serono Ltd. Middlesex, UK) in 0.2 ml PBS (phosphate buffered saline, pH 
7.4, Sigma Aldrich, Dorset, UK) once daily for 7 days. The manufacturer’s datasheet states that 
the hormone preparation  contains no LH activity.  The dose used was based on preliminary 
dose-response studies showing that 8 IU/day caused a maximum increase in testis weight over a 1 
week period. Mice were killed on day 8 (24 h after the last injection) and testes snap frozen in 
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liquid nitrogen or fixed overnight. Fixation was either in Bouin’s for subsequent morphometric 
analysis or 4% paraformaldehyde/1%  gluteraldehyde in phosphate buffer (0.1M, pH 7.4) for 
preparation of semi-thin sections. 
 Testicular morphology in the hpg mouse has been described previously in a number of 
publications (Cattanach et al. 1977; Singh & Handelsman 1996; Myers et al. 2005; Lim et al. 
2008). Spermatogenesis can progress to the pachytene spermatocyte stage in the hpg mouse  and 
numbers of spermatocytes and spermatogonia are similar (Singh & Handelsman 1996; Lim et al. 
2008; Myers et al. 2005). In the hpg mice produced for this study approximately 80% were of this 
phenotype but the remaining 20% of animals had less than 5% of the expected number of  
spermatocytes present. All the mice used in this study are generated by crossing mouse lines 
which are on different backgrounds and it appears likely that the altered phenotype in some 
animals is caused by background effects. Mice with a clear, marked reduction in spermatocyte 
numbers were not used in the study reported here. 
 
Hormone measurements 
Intratesticular levels of testosterone were measured by radioimmunoassay following ethanol 
extraction as previously described (O'Shaughnessy & Sheffield 1990). The limit of detection of 
the assay was 40fmol/ml which equates to 20fmol/testis after extraction. The intra- and inter-
assay coefficients of variation were 6.8 and 12.1%  respectively. Cross reactivity with 
androstenedione and 5α-androstane-3α ,17β-diol was 3.0 and 8.1% respectively  
 
Histology and stereology 
To prepare semi-thin (1µm) sections testes were embedded in araldite and sections stained with 
toluidine blue. For stereological analysis, testes were embedded in Technovit 7100 resin, cut into 
sections (20µm), and stained with Harris’s hematoxylin. The total testis volume was estimated 
using the Cavalieri principle (Mayhew 1992). The optical disector technique (Wreford 1995) was 
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used to count the number of Sertoli cells, germ cells and Leydig cells in each testis. Each cell type 
was identified by previously described criteria (Russell L.D. et al. 1990; Baker & O'Shaughnessy 
2001). The numerical density of each cell type was estimated using an Olympus BX50 
microscope fitted with a motorized stage (Prior Scientific Instruments, Cambridge, UK) and 
Stereologer software (Systems Planning Analysis, Alexandria, VA, USA). Tubule diameter was 
measured directly in a total of at least 36 tubules from 3 sections.  
 
Statistical analysis 
Most data sets were analysed using two factor analysis of variance (anova) with effects of FSH 
and AR deletion as the factors. Where the interaction  between factors was significant this 
indicates that the effect of FSH was altered by deletion of the AR.   To determine whether 
differences between individual groups were significant t-tests were employed using the pooled 
variance from the anova. Data were log transformed where appropriate to avoid heterogeneity of 
variance. Data on intratesticular testosterone were analysed by the non-parametric Kruskal-Wallis 
test followed by the Mann-Whitney test.  
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Figure Legends 
Figure 1 
Effect of FSH on A) testis volume and B) intratesticular testosterone in hpg, hpg.SCARKO and 
hpg.ARKO mice.   In A) data was analysed by 2 factor anova followed by t-tests as described in 
Materials & Methods. An interaction indicates that the effect of FSH was significantly different 
in the three animal groups. In untreated animals, groups with different letter superscripts were 
significantly (P<0.05) different. If  FSH had a significant effect on a particular animal group this 
is indicated by *. Mean ± SEM is shown. Animal numbers,  hpg n = 7; hpg + FSH n = 3; 
hpg.SCARKO n = 5; hpg.SCARKO + FSH n = 4; hpg.ARKO n = 3; hpg.ARKO + FSH n = 3. 
In B) individual values from each animal are shown. The limit of detection of the assay is 
indicated by the broken horizontal line. Data was analysed by the Kruskal-Wallis and Mann-
Whitney tests. FSH had a significant (P<0.05) effect in the hpg mice but had no effect in the other 
animal groups. 
 
Figure 2 
Semi-thin sections showing testicular morphology in hpg, hpg.SCARKO and hpg.ARKO mice 
and in animals treated with FSH.  In untreated animals (A, C, E) spermatogenesis was severely 
disrupted with only spermatogonia and some spermatocytes present. In hpg.ARKO (E) mice 
tubule diameter was smaller and relative interstitial space larger. Treatment with FSH (B, D, F) 
increased tubule diameter and germ cell numbers in all mice although the effect was most marked 
in the hpg. After FSH treatment round spermatids developed in hpg mice (yellow arrow, insert  
B) but not in either hpg.SCARKO or hpg.ARKO mice (inserts D and F). Representative Sertoli 
cells and spermatocytes are indicated by black and white arrows respectively. Photomicrographs 
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are from semi-thin sections of testes fixed in paraformaldehyde/gluteraldehyde apart from the 
inserts  which are from Bouin’s-fixed testes. The bar represents 20µm. 
 
Figure 3 
Effect of FSH on A) tubule diameter,  B) Sertoli cell number and C) Leydig cell number in hpg, 
hpg.SCARKO and hpg.ARKO mice.  An interaction indicates that the effect of FSH was 
significantly different in the three animal groups. In untreated animals, groups with different 
letter superscripts were significantly (P<0.05) different. If  FSH had a significant effect on a 
particular animal group this is indicated by *. Mean ± SEM is shown. Animal numbers,  hpg n = 
6; hpg + FSH n = 3; hpg.SCARKO n = 4; hpg.SCARKO + FSH n = 3; hpg.ARKO n = 3; 
hpg.ARKO + FSH n = 3. 
Figure 4 
Effect of FSH on numbers of A) total germ cell,  B) spermatogonia,  C) spermatocytes and D) 
round spermatids  per testis in hpg, hpg.SCARKO and hpg.ARKO mice.  In untreated animals, 
groups with different letter superscripts were significantly (P<0.05) different. If  FSH had a 
significant effect on a particular animal group this is indicated by *. Mean ± SEM is shown. 
Animal numbers,  hpg n = 6; hpg + FSH n = 3; hpg.SCARKO n = 4; hpg.SCARKO + FSH n = 3; 
hpg.ARKO n = 3; hpg.ARKO + FSH n = 3.  
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Table 1 
Seminal vesicle (SV) weights in hpg and hpg.SCARKO mice 
 
  SV weight (mg) 
Group control plus FSH 
hpg   2.94±0.16 (n=13)    3.40±0.13 (n=30) 
hpg.SCARKO  3.18±0.15 (n=12)    3.65±0.16 (n=19) 
 
There was no significant difference between SV weights in hpg and hpg.SCARKO mice but there was 
a significant (P<0.05) effect of FSH in both groups. Mean ± SEM is reported. 
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Effect of FSH on A) testis volume and B) intratesticular testosterone in hpg, hpg.SCARKO and 
hpg.ARKO mice.   In A) data was analysed by 2 factor anova followed by t-tests as described in 
Materials & Methods. An interaction indicates that the effect of FSH was significantly different in the 
three animal groups. In untreated animals, groups with different letter superscripts were 
significantly (P<0.05) different. If  FSH had a significant effect on a particular animal group this is 
indicated by *. Mean ± SEM of 3 to 6 animals in each group is shown. In B) individual values from 
each animal are shown. The limit of detection of the assay is indicated by the broken horizontal line. 
Data was analysed by the Kruskal-Wallis and Mann-Whitney tests. FSH had a significant (P<0.05) 
effect in the hpg mice but had no effect in the other animal groups.  
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Effect of FSH on A) tubule diameter,  B) Sertoli cell number and C) Leydig cell number in hpg, 
hpg.SCARKO and hpg.ARKO mice.  An interaction indicates that the effect of FSH was significantly 
different in the three animal groups. In untreated animals, groups with different letter superscripts 
were significantly (P<0.05) different. If  FSH had a significant effect on a particular animal group 
this is indicated by *. Mean ± SEM of 3 to 6 animals in each group is shown.  
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